These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12773085)

  • 1. Hormonal birth control and pregnancy: a comparative analysis of thromboembolic risk.
    Wilks JF
    Ann Pharmacother; 2003 Jun; 37(6):912-6. PubMed ID: 12773085
    [No Abstract]   [Full Text] [Related]  

  • 2. [Proper education for the patient! Risk of thromboembolism with oral contraception].
    Wenderlein JM
    MMW Fortschr Med; 2000 Feb; 142(7):38-9. PubMed ID: 10832333
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hormonal contraception and thromboembolic disease. I. Epidemiologic data].
    Paseka J; Unzeitig V
    Ceska Gynekol; 1997 Apr; 62(2):75-8. PubMed ID: 9296797
    [No Abstract]   [Full Text] [Related]  

  • 4. Risks of oral contraceptives.
    Roberts H; McCowan L; Roke C; Liddell H; Batcheler L; Thakurdas N; Wilson J
    N Z Med J; 1987 Jul; 100(827):430-1. PubMed ID: 3452077
    [No Abstract]   [Full Text] [Related]  

  • 5. Hormonal contraception and venous thromboembolic risk in midlife women.
    Lidegaard Ø
    Maturitas; 2013 Jan; 74(1):1-2. PubMed ID: 23098858
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral steroid contraception.
    Sech LA; Mishell DR
    Womens Health (Lond); 2015 Nov; 11(6):743-8. PubMed ID: 26673988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormonal contraception--throboembolism and surgical risk].
    Göretzlehner G; Frick G; Frick U
    Zentralbl Gynakol; 1976; 98(10):600-10. PubMed ID: 961166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Estrogen-progestin contraception and cardiovascular diseases: the end of polemics on the third generation].
    Jamin C
    Contracept Fertil Sex; 1998 May; 26(5):331-7. PubMed ID: 9648376
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new test system for evaluating the risk of thromboembolism in the use of hormonal contraceptives].
    Pechlaner C; Kunz F; Tabarelli M; Sölder E; Zwierzina WD; Reitsamer R; Koch R
    Gynakol Rundsch; 1989; 29 Suppl 2():312-4. PubMed ID: 2613036
    [No Abstract]   [Full Text] [Related]  

  • 10. Family history and risk of venous thromboembolism with oral contraception. Family history is important tool.
    Vandenbroucke JP; van der M eer FJ; Helmerhorst FM; Rosendaal FR
    BMJ; 2001 Sep; 323(7315):752. PubMed ID: 11675729
    [No Abstract]   [Full Text] [Related]  

  • 11. [The pill and thromboembolism. 2. Pathogenesis and additional risk factors. Review of the literature].
    Herzog C; Mall-Haefeli M
    Ther Ggw; 1979 Nov; 118(11):1722-44. PubMed ID: 395715
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hormonal contraceptive agents as a risk factor in the development of acute thromboembolic diseases].
    Lambrekht R; Vageman V; Vinkelman B; Geĭnrikh P
    Khirurgiia (Mosk); 1986 Dec; (12):90-3. PubMed ID: 3821001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contraception for women with systemic lupus erythematosus.
    Culwell KR; Curtis KM
    J Fam Plann Reprod Health Care; 2013 Jan; 39(1):9-11. PubMed ID: 23104972
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral contraceptives and venous thromboembolism.
    Savage RL
    N Z Med J; 1997 Mar; 110(1040):109. PubMed ID: 9137318
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral contraceptives and hypercoagulation.
    Petitti DB
    Clin Adv Hematol Oncol; 2006 Nov; 4(11):813-5. PubMed ID: 17143250
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormones and pregnancy: thromboembolic risks for women.
    Kujovich JL
    Br J Haematol; 2004 Aug; 126(4):443-54. PubMed ID: 15287937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hormonal contraception--thromboembolic disorders and surgical risk (author's transl)].
    Göretzlehner G; Frick G; Frick U
    Zentralbl Chir; 1976; 101(18):1103-11. PubMed ID: 983453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
    Meurer LN; Slawson JG
    J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
    [No Abstract]   [Full Text] [Related]  

  • 19. Estrogen and thromboembolic disorders: should patients stop hormones prior to cosmetic surgery?
    Shiffman MA
    J Womens Health (Larchmt); 2003 Nov; 12(9):853-5; discussion 855. PubMed ID: 14670164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is it really necessary to discontinue hormonal contraceptives before carrying out a planned operation?].
    Zentralbl Gynakol; 1989; 111(11):771-80. PubMed ID: 2781890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.